Impact of Functional Status on Noncardioembolic Ischemic Stroke Recurrence Within 1 Year: The Korean Stroke Cohort for Functioning and Rehabilitation Study by 源��뜒�슜
54  Copyright © 2019 Korean Neurological Association  
Background and Purpose  Few studies have investigated the relationship between the spe-
cific functional factors potentially associated with functional level and stroke recurrence. We 
conducted a study of patients with noncardioembolic ischemic stroke (NCIS) to determine 
the functional factors affecting recurrence within the first year.
Methods  In total, 568 first-ever NCIS patients (age=65.1±17.4 years, mean±SD) were ana-
lyzed in a multicenter, prospective cohort study registered from August 2012. Demographic 
characteristics, past medical history, comorbidities, laboratory data, stroke features in neuro-
imaging, acute treatments, and medications at discharge were assessed. Functional factors re-
flecting gross functional impairment, ambulatory function, motor function, activities of daily 
living, cognition, language ability, swallowing function, mood, and quality of life were compre-
hensively evaluated in face-to-face assessments using standardized tools at the time of discharge.
Results  The cumulative incidence of stroke recurrence in NCIS was 6.0% (n=34) at 1 year. 
The period from admission to discharge was 34.4±7.0 days. The independent predictors of 
stroke recurrence within 1 year in multivariate Cox proportional-hazards regression analyses 
were 1) age [per-year hazard ratio (HR)=1.04, 95% confidence interval (CI)=0.97–1.06, 
p=0.048], 2) Charlson Comorbidity Index higher than 2 (HR=1.72, 95% CI=1.26–2.22, p= 
0.016), 3) modified Rankin Scale score of 3 or more at discharge (HR=1.56, 95% CI=1.22–1.94, 
p=0.032), and 4) Functional Ambulation Category of 3 or less at discharge (HR=2.56, 95% CI= 
1.84–3.31, p=0.008).
Conclusions  In addition to patient age, moderate-to-severe functional impairment requiring 
the help of others (especially for ambulation) at the time of discharge and the severity of comor-
bidity were independent predictors of stroke recurrence within 1 year of the first NCIS.
Key Words   comorbidity, disability evaluation, function, recurrence, stroke.
Impact of Functional Status on Noncardioembolic Ischemic 
Stroke Recurrence Within 1 Year: The Korean Stroke Cohort 
for Functioning and Rehabilitation Study
INTRODUCTION
Compared to first-ever stroke, recurrent stroke is responsible for greater disability, with more-
severe physical, psychological, and social impairments.1 Previous community-based stud-
ies have revealed that 8–12% of stroke patients experience recurrence within 1 year after an 
initial stroke.1-3 Risk factors for stroke recurrence include prior stroke, hypertension, heart 
failure, diabetes, hyperlipidemia, metabolic syndrome, and poor lifestyle,4-7 and these factors 
have been extensively investigated for secondary stroke prevention. Stroke subtype, neuro-
imaging findings, and several blood markers are also well-recognized risk factors for recur-
rence, but these factors cannot be modified.8,9
While the current approach to secondary prevention primarily focuses on controlling these 
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risk factors, there has been unsatisfactory progress in pre-
venting recurrence. Functional status and rehabilitation are 
also recently identified factors that are significant for recur-
rence.10,11 Functional status refers to the ability of an individual 
to perform the normal daily activities required to meet basic 
needs, fulfill usual roles, and maintain health and well-be-
ing.12,13 Functional status subsumes related concepts of inter-
est; functional capacity and functional performance.12 While 
functional capacity represents the capacity of an individual to 
perform daily activities in the physical, psychological, social, 
and spiritual domains of life, functional performance refers 
to the activities that people actually participate in during the 
course of their daily lives.12 Functional impairment means the 
loss of functional status, and it was used in the restricted sense 
of activity limitation in the present study.14 For example, Park 
and Ovbiagele11 reported stepwise relationships between in-
creasing disability and risk of recurrent stroke that contrasted 
with the outcomes in patients with no disability. Impaired 
physical activity is a major risk factor for stroke occurrence, 
and exercise is recommended to prevent stroke and cardiovas-
cular events.15 In addition, early functional recovery after 
stroke can enable survivors to increase their active physical ac-
tivity and thereby ultimately reduce the probability of stroke 
recurrence.
However, there has been little research into the potential 
associations of specific functional indicators with functional 
impairment and stroke recurrence. It is especially necessary 
to establish an appropriate rehabilitation strategy to prevent 
recurrence. Therefore, we conducted a prospective observa-
tional study of patients with noncardioembolic ischemic 
stroke (NCIS) to determine functional indicators that affect 
recurrence within the first year. 
METHODS
Patient selection 
This study was based on the Korean Stroke Cohort for Func-
tioning and Rehabilitation (KOSCO) report.16 The study pro-
tocols were approved by the ethics committee of each hospital. 
The study objectives, design, and risks/benefits were explained 
to the patients, and written informed consent was obtained 
upon hospitalization. The study protocols were approved by 
the ethics committee of each hospital (IRB No. WKUH-1515).
This study enrolled 882 first-ever NCIS patients transferred 
to a department of rehabilitation after being treated for acute 
stroke (Fig. 1). Trial of Org 10,172 in Acute Stroke Treatment 
(TOAST) criteria were used to detect NCIS.17 These ischemic 
stroke subtypes were determined by stroke neurologists at 
each participating hospital based on neuroimaging findings, 
medical history, and use of medication. The patients were dis-
charged from the participating hospitals after undergoing 
inpatient rehabilitation for approximately 3 weeks. Patients 
who died (n=19) due to causes other than stroke recurrence 
or were lost to follow-up (n=76) during the 1-year analysis pe-
riod were excluded. The causes of death of these patients were 
as follows: pneumonia (n=11), cardiac event (n=3), cancer (n= 
2), traffic accident (n=2), and liver cirrhosis (n=1). Among 
the 787 patients who completed follow-up, hemorrhagic (n= 
150) and cardioembolic ischemic stroke (n=69) patients were 
excluded. Therefore, 568 patients with NCIS were finally se-
lected for this study.
Demographic and clinical assessments
A complete data survey of all patients was conducted based 
on a review of medical records. Items including demographic 
data, cerebrovascular risk factors, and family/social history were 
Stroke patients transferred to the department of 
rehabilitation (n=882)
Patients who were completed follow-up for 1 year (n=787)
Patients with non-cardioembolic stroke (n=568)
Recurrence (n=34)
Death of causes other than recurrence (n=19)
Follow-up loss (n=76)
No recurrence (n=534)
Hemorrhagic stroke (n=150) 
Cardioembolic stroke  (n=69)
Fig. 1. Patient selection flowchart.
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surveyed using standardized, structured questionnaires. The 
National Institutes of Health Stroke Scale (NIHSS) was used to 
evaluate the severity of neurological deficits in the emergency 
room. Comorbidities were assessed using the Charlson Co-
morbidity Index (CCI), which contains 19 categories of co-
morbidity and predicts the mortality of patients who may have 
a range of comorbid conditions.18-20 Because higher CCIs in-
dicate greater comorbidities, we divided the patients into two 
groups based on a CCI of 2 points, and analyzed the risk of re-
currence separately in these groups.18 Laboratory data, stroke 
features, acute treatments, and medications commonly pre-
scribed at discharge were assessed. 
Functional status evaluation
Comprehensive face-to-face functional evaluations were per-
formed at discharge. All evaluations were conducted by re-
search assistants who were sufficiently trained and rigorously 
tested. The functional status in terms of the level of depen-
dency, ambulation, motor function, activities of daily living, 
cognition, language ability, swallowing function, mood, and 
health-related quality of life were evaluated extensively at dis-
charge after receiving stroke rehabilitation using the follow-
ing standardized tools: modified Rankin Scale (mRS),21 Func-
tional Ambulation Category (FAC),22 Fugl-Meyer Assessment 
(FMA),23 Functional Independence Measure (FIM),24 Korean 
version of the Mini Mental State Examination (K-MMSE),25 
Korean version of the Frenchay Aphasia Screening Test (K-
FAST),26 American Speech-Language-Hearing Association 
National Outcome Measurement System Swallowing Scale 
(ASHA-NOMS),27 Geriatric Depression Scale–Short Form 
(GDS-SF),28 and EuroQoL-5 Dimensions (EQ-5D),29 respec-
tively (Supplementary Table 1 in the online-only Data Supple-
ment).
Several functional indicators were analyzed after dichoto-
mization according to the degree of dependence or severity 
in order to establish possible rehabilitation strategies in the 
future. For example, a mRS score of 3 or more indicates that 
the patient has moderate-to-severe functional impairment, and 
a FAC score of 3 or less means that the patient requires man-
ual contact with another person during ambulation on level 
surfaces. The FMA motor score was divided into two groups 
according to the severity: mild (>79) and moderate to severe 
(0–79).23 The FIM ranges from 18 to 126 points and is a com-
mon tool used for assessing the ability to perform the activi-
ties of daily living.24 These assessments were performed in the 
present study based on dividing the level of dependence on 
others into two groups: mild (>90) and moderate to severe 
(18–90).24 The K-MMSE score was analyzed by dividing the 
patients into two groups, with scores of 0–23 points indicat-
ing moderate-to-severe cognitive impairment and scores of 
more than 23 points indicating mild cognitive dysfunction.25 
The ASHA-NOMS scores were also analyzed by dividing pa-
tients into two groups corresponding to normal (7 points) and 
abnormal (≤6 points) swallowing function.
Identification of stroke recurrence within 1 year
Detailed information about stroke recurrence was collected 
at 3 months, 6 months, and 1 year after stroke onset. All pa-
tients were approached for follow-up assessments using a two-
step approach.16 We first regularly obtained follow-up infor-
mation via telephone interviews with the patients themselves 
or their caregivers. All of the survivors were subsequently in-
vited to visit the outpatient clinics of the hospitals where they 
were first admitted to complete a battery of functional assess-
ments, structured self-administered questionnaires, and face-
to-face interviews. If patients were not able to return for the fol-
low-up assessments, research assistants visited the patients 
at their homes to perform these same evaluations. Stroke re-
currence was confirmed based on the medical records of each 
participating hospital whenever the patients themselves or 
their caregivers reported recurrence during these follow-up 
initiatives.
Statistical analysis
We used univariate Cox proportional-hazards regression to 
identify differences in baseline characteristics between patients 
with and without recurrence. Hazard ratios (HRs) and 95% 
confidence intervals (CIs) were calculated using the univari-
ate Cox proportional-hazards model. We also determined the 
risk of subsequent stroke recurrence in relation to each vari-
able by using multivariate Cox proportional-hazards regres-
sion analysis. A backward conditional procedure was per-
formed using p>0.10 in the likelihood ratio test for exclusion. 
The regression model included the time to recurrent stroke 
as the response, and clinical/functional predictors of recur-
rence with a univariate probability value of p<0.1 as an inde-
pendent variable. Because sex and the initial NIHSS score 
measured in the emergency room are well-known factors in-
volved in stroke recurrence,30-32 these factors were additionally 
included and analyzed in the final model. The Kaplan-Meier 
method was used to evaluate the distribution of time to events 
according to the characteristics derived from the multivariate 
Cox proportional-hazards regression analysis. Intergroup 
comparisons were performed using the log-rank test. A prob-
ability value of p<0.05 was considered significant. All analyses 
were performed using SPSS statistical software (version 22.0; 
IBM Corp., Armonk, NY, USA).
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Table 1. Clinical characteristics of the patients and HRs from the univariate Cox proportional-hazards regression analyses for stroke recurrence
Recurrence: yes (n=34, %) Recurrence: no (n=534, %) HR (95% CI) p
Baseline characteristics
Age, years 70.3±13.0 63.7±19.4 1.04 (0.97–1.06) 0.016*
Sex, male 60 58 1.21 (0.67–1.82) 0.309
BMI, kg/m2 23.1±3.1 23.5±3.4 0.96 (0.90–1.02) 0.209
Marital status, married 79 78 1.17 (0.45–2.02) 0.470
Education, ≥high school 48 49 1.00 (0.38–1.62) 0.992
Family history 11 9 1.48 (0.98–2.12) 0.169
Smoking 57 53 1.06 (0.82–1.35) 0.771
Alcohol 65 62 1.11 (0.74–1.55) 0.582
CCI, >2 27 15 2.20 (1.30–3.24) 0.008*
Past medical history
Hypertension 61 58 1.05 (0.46–1.67) 0.781
Diabetes mellitus 30 29 1.34 (0.40–2.33) 0.134
Ischemic heart disease 8 7 1.20 (0.52–1.73) 0.596
Atrial fibrillation 8 6 1.80 (1.02–3.03) 0.060*
Hyperlipidemia 13 10 1.73 (1.12–2.88) 0.055*
Initial neurological deficits in the emergency room
NIHSS score 8.6±6.2 9.5±6.9 1.01 (0.74–1.52) 0.325
Laboratory data on admission
Fasting glucose, mg/dL 101±16 104±18 1.00 (0.89–1.11) 0.681
Total cholesterol, mg/dL 176±41 178±44 0.99 (0.95–1.05) 0.325
LDL-C, mg/dL 105±32 108±36 1.00 (0.89–1.09) 0.483
HDL-C, mg/dL 45±13 46±17 0.98 (0.90–1.06) 0.889
Triglycerides, mg/dL 124±76 121±78 1.00 (0.88–1.12) 0.450
Creatinine, mg/dL 0.9±0.6 1.0±0.6 0.94 (0.90–1.00) 0.699
Homocysteine, µmol/L 10.7±17.5 9.2±10.6 1.01 (0.86–1.16) 0.812
Stroke features
Lesion side, left 50 46 0.83 (0.39–1.69) 0.296
Location, brain stem 30 30 1.07 (0.68–1.52) 0.729
Subtypes
LAA 81 77 2.19 (1.33–3.42) 0.028*
Small-vessel occlusion 18 21 1.02 (0.60–1.45) 0.113
Others 1 2
Acute-phase therapies
IV tPA 5 6 0.85 (0.49–1.16) 0.712
IA tPA 5 4 1.46 (0.68–2.32) 0.224
IV heparin 9 10 1.18 (0.63–1.94) 0.328
Antiplatelet 81 80 1.44 (1.02–1.82) 0.123
Medications at discharge
Antiplatelet 71 76 0.84 (0.45–1.26) 0.443
Anticoagulation 10 10 0.99 (0.82–1.19) 0.220
Antihypertensive 47 41 1.26 (0.94–1.66) 0.199
Antidiabetic 24 19 1.08 (0.79–1.28) 0.748
Antilipid 73 68 1.20 (0.93–1.63) 0.347
Noncategoric data are expressed as mean±SD values. Categoric data are expressed as percentage values.
*p<0.10.
BMI: body mass index, CCI: Charlson Comorbidity Index, CI: confidence interval, HDL-C: high-density lipoprotein cholesterol, HR: hazard ratio, IA: intra-
arterial, IV: intravenous, LAA: large-artery atherosclerosis, LDL-C: low-density lipoprotein cholesterol, NIHSS: National Institutes of Health Stroke Scale, 
tPA: tissue plasminogen activator.
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RESULTS
This study analyzed 568 patients (age=65.1±17.4 years, mean± 
SD; 318 males and 250 females), of which 34 patients expe-
rienced recurrent stroke during the 1-year observation period, 
giving a recurrence rate following NCIS of 6.0% (34/568). 
Four patients died due to stroke recurrence. The period to dis-
charge after stroke onset was 34.4±7.0 days, and we identi-
fied that NCIS was caused by large-artery atherosclerosis in 446 
(79%) patients, small-vessel occlusion in 108 (19%) patients, 
and another cause in 14 (2%) patients.
Univariate analyses
The clinical characteristics, laboratory data, stroke features, 
and medications prescribed at discharge are presented in Ta-
ble 1. Age (HR=1.04, 95% CI=0.97–1.06, p=0.016), a CCI 
higher than 2 (HR=2.20, 95% CI=1.30–3.24, p=0.008), atrial 
fibrillation (HR=1.80, 95% CI=1.02–3.03, p=0.060), hyperlip-
idemia (HR=1.73, 95% CI=1.12–2.88, p=0.055), and large-ar-
tery atherosclerosis (HR=2.19, 95% CI=1.33–3.42, p=0.028) 
were significantly associated with stroke recurrence. 
Table 2 presents the results for the functional factors asso-
ciated with the risk of stroke recurrence. The period to dis-
charge after stroke onset was 34.8±6.8 days in the patients 
with recurrent stroke and 34.2±7.0 days in those who were 
recurrence-free during the 1-year analysis period. Significant 
associations with the risk of stroke recurrence were found for 
an mRS score of 3 or more (HR=1.85, 95% CI=1.28–2.54, p= 
0.010), an FAC score of 3 or less (HR=3.89, 95% CI=2.32–5.65, 
p<0.001), and an FMA motor score of 79 or less (HR=1.46, 
95% CI=1.02–1.90, p=0.048).
Multivariate analyses
A subsequent analysis was performed of all significant vari-
ables after the univariate analyses. As indicated in Table 3, 
the independent predictors of stroke recurrence within 1 
year after onset in the multivariate Cox proportional-hazards 
regression analysis were 1) patient age (per-year HR=1.04, 
95% CI=0.97–1.06, p=0.048), 2) CCI higher than 2 (HR= 
1.72, 95% CI=1.26–2.22, p=0.016), 3) mRS score of 3 or more 
Table 2. Functional status assessed at discharge and the results of the univariate Cox proportional-hazards regression analysis
  Functional indicator Recurrence: yes (n=34, %) Recurrence: no (n=534, %) HR (95% CI) p
mRS score, ≥3 42 35 1.85 (1.28–2.54) 0.010*
FAC score, ≤3 47 34 3.89 (2.32–5.65) <0.001*
FMA motor score, 0–79 48 42 1.46 (1.02-1.90) 0.048*
FIM, 18–90 50 46 1.34 (0.94–1.74) 0.126
K-MMSE score, 0–23 49 51 1.12 (0.86–1.40) 0.233
K-FAST score 6.1±1.7 6.2±1.6 1.04 (0.80–1.28) 0.421
ASHA-NOMS score, ≤6 32 29 0.78 (0.29–1.33) 0.250
GDS-SF score 2.6±1.6 2.2±1.5 0.99 (0.80–1.19) 0.407
EQ-5D score 0.65±0.37 0.60±0.35 1.01 (0.98–1.04) 0.207
Period to discharge, days 34.8±6.8 34.2±7.0 0.93 (0.84–1.04) 0.124
Noncategoric data are expressed as mean±SD values. Categoric data are expressed as percentage values.
*p<0.10.
ASHA-NOMS: American Speech-Language-Hearing Association National Outcome Measurement System Swallowing Scale, CI: confidence interval, 
EQ-5D: EuroQoL-5 Dimensions, FAC: Functional Ambulation Category, FIM: Functional Independence Measure, FMA: Fugl-Meyer Assessment, GDS-SF: 
Geriatric Depression Scale-Short Form, HR: hazard ratio, K-FAST: Korean version of the Frenchay Aphasia Screening Test, K-MMSE: Korean version of 
the Mini Mental State Examination, mRS: modified Rankin Scale.
Table 3. Results of multivariate Cox proportional-hazards regression analyses for stroke recurrence
HR 95% CI p
Age 1.04 0.97–1.06 0.048*
Sex, male 1.08 0.87–1.30 0.374
NIHSS score in the emergency room 1.01 0.84–1.18 0.538
CCI, >2 1.72 1.26–2.22 0.016*
LAA 1.23 1.06–1.59 0.082
mRS score at discharge, ≥3 1.56 1.22–1.94 0.032*
FAC score at discharge, ≤3 2.56 1.84–3.31 0.008*
*p<0.05.
CCI: Charlson Comorbidity Index, CI: confidence interval, FAC: Functional Ambulation Category, HR: hazard ratio, LAA: large-artery atherosclerosis, 
mRS: modified Rankin Scale, NIHSS: National Institutes of Health Stroke Scale.
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(HR=1.56, 95% CI=1.22–1.94, p=0.032), and 4) FAC score of 3 
or less (HR=2.56, 95% CI=1.84–3.31, p=0.008). According to 
the Kaplan-Meier analysis, there were significant differences 
in recurrence-free survival between patients with mRS score 
≥3 and mRS score <3 at discharge (p=0.034, log-rank test), 
and between patients with FAC score ≤3 and FAC score >3 
at discharge (p=0.016, log-rank test) (Fig. 2). In addition, the 
recurrence-free survival period was significantly shorter for 
patients with CCI >2 than for those with CCI ≤2 (p=0.028, 
log-rank test).
DISCUSSION
The present study found that functional impairment (espe-
cially ambulatory function) at discharge, age, and the severity 
of comorbidities were independent predictors of recurrence 
within 1 year after the onset of NCIS. The results of this study 
imply that applying other interventions to promote function—
in addition to previously developed medical treatments for 
secondary stroke prevention—may reduce the probability of 
stroke recurrence.
The functional status based on the mRS score after simpli-
fication into two categories (no or slight functional impair-
ment and moderate-to-severe functional impairment) was a 
strong indicator of recurrence. It was previously shown that 
functional impairment at approximately 1 month poststroke 
is related to long-term functional outcome,21 and the present 
results are similar to those reported previously.11,33 It was re-
ported that compared to no/slight functional impairment (mRS 
score ≤2), moderate functional impairment (mRS score=3) 
after a recent NCIS was independently associated with an al-
most 1.5-fold higher risk of recurrent stroke within 2 years.11 
The mRS did not indicate impairment of any specific func-
tional domains, since it is an index of the overall dependence 
according to the severity of gross functional impairment.34 
However, the previous study did not precisely consider what 
functional deficits were underlying these findings. Instead, 
reactive depression arising from clearly more-disabling con-
sequences, and vitamin D deficiency due to limited mobility 
and decreased sunlight exposure were thought to be the fac-
tors underlying the low mRS scores and stroke recurrence.11 
In contrast, our present comprehensive analysis of overall 
functional indicators has confirmed that ambulatory func-
tion is a critical factor for stroke recurrence. Those patients 
who needed help from others or were not able to walk at all 
(FAC score ≤3) were approximately 2.5-fold more likely to 
experience recurrence than those who did not have such defi-
cits. The underlying mechanisms linking ambulatory func-
tion and stroke recurrence remain unclear, but they can be in-
ferred from several reports. Kono et al.35 reported that physical 
activity quantified based on the step count during ambula-
tion was an independent predictor of the recurrence of vascu-
lar events (68% for stroke and 32% for coronary heart dis-
ease) in stroke survivors. It is widely known that lifestyle 
modifications for secondary stroke prevention significantly 
reduce the probability of stroke recurrence and other vascu-
lar events, and physical activity also tends to be associated with 
stroke recurrence.7,36,37 Another study found that walking itself 
enhanced endogenous fibrinolysis by increasing tissue plas-
minogen activator and decreasing the activity of plasminogen 
activator inhibitor PAI-1 in stroke patients.38 Moreover, Cheng 
et al.10 discovered that rehabilitation during the first year af-
ter stroke was significantly associated with a lower incidence 
of recurrent stroke and all-cause mortality. Therefore, a reha-
bilitation strategy that focuses on the recovery of ambulatory 
function should be strongly considered to prevent recurrence.
Comorbidity was also a strong predisposing factor for re-
currence in patients with NCIS. Although there has been lit-
tle research into the relevance of comorbidities to stroke re-
currence, a few possible mechanisms can be considered. It is 
known that the CCI is a strong predictor of both mortality and 
stroke occurrence.18,39 A previous comparison of very severe 
comorbidity with no comorbidity found ischemic stroke in-
creased both the 30-day and 5-year mortality rates by approx-
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imately 2.5-fold.18 Comorbidity is also an important factor 
in poststroke functional recovery.40 Insufficient rehabilita-
tion therapies and repeated hospitalization due to multiple 
comorbidities contribute to poor functional outcomes.41 Poor 
functional recovery in patients with multiple comorbidities 
cause decreased physical activity and deconditioning,42,43 which 
lead to arterial stiffness, increased atherosclerosis, and fail-
ure to control other stroke risk factors.43,44 These processes 
were therefore considered to increase the probability of stroke 
recurrence. 
Several limitations of the present study should be consid-
ered when interpreting its findings. We confirmed stroke re-
currence after calling the patients themselves or their caregivers 
by telephone at each time point. Although the research assis-
tants visited the homes of the patients after establishing phone 
contact, a limitation was the difficulty of determining recur-
rence if the patients or caregivers could not be reached by 
telephone. Furthermore, a larger number of recurrent stroke 
patients may be missed by our protocol compared with a 
methodology utilizing a nationwide stroke registry to identify 
recurrence. The functional data at discharge of the patients 
who were not followed up are summarized in Supplementary 
Table 1 (in the online-only Data Supplement). We thought 
that patients with greater functional impairment due to neu-
rological deficits were more likely to be lost to follow-up, but 
there were no differences in functional status. We consider it 
most likely that these patients stopped participating in the 
research intentionally during the follow-up for personal rea-
sons. The degree of compliance with the protocol of this study 
was not investigated, and so the factors influencing compli-
ance should be analyzed in a future study. Although the 76 
patients who were lost to follow-up within 1 year accounted 
for a small proportion of the overall population, their exclu-
sion may have influenced the results. In addition, informa-
tion on adherence to medications for secondary prevention 
and good health-related behaviors was not collected during 
the follow-up. In Korea, medication prescriptions for second-
ary prevention and educating about health-related behaviors 
are mainly the responsibility of neurologists. However, the re-
searchers visiting the present patients received regular training 
about medications and habitual education. They also taught 
the patients to comply with taking their medications and follow 
their instructions for behavioral changes during every visit. 
However, the actual compliance with these activities was not 
investigated in this study.
In conclusion, moderate-to-severe functional impairment 
at the time of discharge requiring the help of others (espe-
cially for ambulation) and the severity of comorbidity in ad-
dition to age were confirmed to be independent risk factors 
for stroke recurrence within 1 year of onset in patients with 
NCIS. Additional treatments focused on the recovery of am-
bulatory function may be a good strategy for preventing stroke 
recurrence.
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The online-only Data Supplement is available with this arti-
cle at https://doi.org/10.3988/jcn.2019.15.1.54.
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